On April 28, 2022, Martin Latterich, Ph.D., informed Histogen Inc. that he would be resigning from his position as Senior Vice President of Technical Operations of the Company. Dr. Latterich's decision to step down as an officer of the Company was to pursue another opportunity and not the result of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 USD | 0.00% | 0.00% | -44.75% |
04-19 | Subchapter V Trustee Appointed Under Chapter 11 for Histogen Inc. | CI |
04-18 | Histogen Inc. Filed for Bankruptcy | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.75% | 726K | |
+8.38% | 115B | |
+10.13% | 105B | |
-11.69% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.00% | 16.01B | |
+2.28% | 14.14B | |
+20.54% | 10.71B |
- Stock Market
- Equities
- HSTO Stock
- News Histogen Inc.
- Histogen Inc. Announces Resignation of Martin Latterich as Senior Vice President